Survey Finds Hybrid Strain Most Used in Patients With Chronic Pain, Migraines and Headaches
A new survey examines the use of medical cannabis in patients with chronic pain. Especially in cases of headaches, migraines and headaches. The results provide us with new information on the types of strains used, as well as their terpenes profile. It also provides in detail the "biochemical profiles" of the plants used by these same patients.
Medical cannabis effective against chronic pain
Patients with chronic pain are increasingly using medical cannabis instead of conventional painkillers. A new study published in the Journal of Headache and Pain confirms this state of affairs. Chronic pain was the most common reason for cannabis use, which is consistent with most data.
"There is a multitude of studies showing the benefits of cannabis in many forms of chronic pain."
According to an 2016 analysis of the Marijuana Business Daily, 64% of patients suffering from severe or chronic pain reported using medical cannabis. Some studies, such as the one published in 2016 by researchers at the University of Colorado, have shown that the frequency of migraines in patients can be reduced with medical cannabis.
Headache is the main symptom treated with cannabis
This new survey revealed that almost a quarter of 2032 respondents asked for medical cannabis to treat headaches. Among the patients suffering from headaches, 88% "Were treating probable migraines with cannabis".
But as the survey reveals, few studies tend to differentiate the types of strains as well as the associated compositions of cannabinoids and terpenes that may be most effective in this type of symptom.
The effective "biochemical profile"
The use of cannabis for migraine in patients with headache was assessed via the electronic questionnaire, Migraine ID ™. It is also a valid test to predict the likelihood of migraine. As a result of this questionnaire, some hybrid cannabis strains have a biochemical profile of the most effective. In addition, the study also proved that hybrid strains, intersecting Sativa and Indica, are the most popular.
According to the survey the strainOG Shark"Often comes up in the preferences of patients. The strain has a high content of THC (Δ9-tetrahydrocannabinol) and THCA (tetrahydrocannabinolic acid). However, it is low in CBD (cannabidiol) and CBDA (cannabidiolic acid).
OG Shark contains the predominant terpenes ß-caryophyllene and ß-myrcene. Terpenes are also recommended for headache and migraine. This could reflect the analgesic, anti-inflammatory and powerful anti-emetics THC. It combines with the anti-inflammatory and analgesic properties of β-caryophyllene and β-myrcene.
Opiates / opioids were most often substituted for cannabis. Prospective studies are needed, but the results can provide insights into the optimization of hybrid cannabis strains, synergistic biochemical profiles, dosage, and patterns of use in the treatment of headaches, migraine headaches, and migraine syndromes. Chronic Pain.